MISRII EVs
€1,700.00
Tax excluded
EVs bioengineered with human MISRII receptor
MISRII EVs, innovative bioengineered EVs harbouring MISRII receptor (Muellerian inhibiting substance type II)
MISRII EVs are produced by human embryonic kidney (HEK) 293T cells and purified according to in-EV purification process. These pure EVs are characterised using standardised quality controls. MISRII receptor is targeted to the EV membrane using Ciloa technology, which does not overexpress or modify natural EV proteins.
MISRII EVs are interesting tools that can be used to:
- Study molecular interactions with ligands, specific antibodies or small molecules
- Characterise MISRII receptor using technologies like SPR or other
Specifications
| Total protein quantity of pure EVs | 50 µg |
| Particle number (Nano-flow cytometry) | ≥ 8E+09 particles |
| Particle size (Nano-flow cytometry) | Median size of 60-70 nm |
| Source | HEK293T cells |
| Buffer | PBS 1X – BSA 10 µg/mL |
| Storage | Store sterile at +4°C up to 6 months |
Strengths of MISRII EVs
- 100% fully native receptor embedded with its right topology on EV membrane.
- Bioengineered EVs using Ciloa technology, no overexpression or modification of natural EV proteins.
- Storage at +4°C, in a simple buffer, for several months when kept sterile.
X139_50